RAINA PATEL: Open Payments
NPI 1689302374 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 55 payments from 18 companies in 2025. Trend: 2023 $1,503 · 2024 $1,411 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $284 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $91 |
| Lilly USA, LLC | 5 | $90 |
| PFIZER INC. | 3 | $62 |
| Novo Nordisk Inc | 3 | $60 |
| Amgen Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
Products named: VRAYLAR, XIFAXAN, MOUNJARO, SHINGRIX, BREZTRI, TRELEGY ELLIPTA, Cologuard Collection Kit, PREVNAR 20.
Industry payments across CO — which companies pay providers there.
